Bismuth as a relatively non-toxic and inexpensive metal with exceptional properties has
numerous biomedical applications. Bismuth-based compounds are used extensively as …

Radiopharmaceuticals are rapidly develo** as a field, with the successful use of targeted
beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted …

Targeted alpha therapy (TAT) using alpha particle-emitting radionuclides is in the spotlight
after the approval of 223RaCl2 for patients with metastatic castration-resistant prostate …

Introduction Metastatic cutaneous squamous cell carcinoma (cSCC) is a very rare condition.
The lack of definition of an oligometastatic subgroup means that there is no consensus for its …

Immuno-oncology is a rapidly evolving field with growing relevance in the treatment of
numerous malignancies. The prior study of immunotherapy in dermatologic oncology has …

Abstract Background Diffusing alpha‐emitters Radiation Therapy (“DaRT”) is a new method,
presently in clinical trials, which allows treating solid tumors by alpha particles. DaRT relies …

Malignant mesothelioma, a highly aggressive cancer that primarily affects the serosal
membranes, has limited therapeutic options, particularly for cavitary tumors, such as …

The delivery of radiation therapy (RT) for cancer with intent to cure has been optimized and
standardized over the last 80 years. Both preclinical and clinical work emphasized the …

Oncoimmunology represents a biomedical research discipline coined to study the roles of
immune system in cancer progression with the aim of discovering novel strategies to arm it …

Diffusing alpha-emitting radiation therapy (DaRT) employs intratumoral Ra-224-coated
seeds that efficiently destroy solid tumors by slowly releasing alpha-emitting atoms inside …